Rational design of nonnatural peptides as high-affinity ligands for the HLA-B*2705 human leukocyte antigen.
- 31 January 1995
- journal article
- Published by Proceedings of the National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 92 (3) , 753-757
- https://doi.org/10.1073/pnas.92.3.753
Abstract
From the three-dimensional structure of the class I major histocompatibility complex (MHC) HLA-B*2705 protein, several nonnatural peptides were designed either to optimize the interactions of one peptide amino acid (position 3) with its HLA binding pocket (pocket D) or to simplify the T-cell receptor-binding part by substitution with organic spacers. The stability of each MHC-ligand complex was simulated by 150-ps molecular dynamics in a water environment and compared with that of the natural complexes. All peptides were synthesized and tested for binding to the class I MHC protein in an in vitro assembly assay. As predicted from the computed atomic fluctuations and buried surface areas of MHC-bound ligands, bulky hydrophobic side chains at position 3 enhance the binding of a nonameric peptide to the HLA-B27 protein. Furthermore, it was possible to simplify half of the peptide sequence (residues 4-8) by replacement with organic fragments without altering the affinity of the designed ligands for the class I MHC protein. This study constitutes an initial step toward the rational design of nonpeptide class I MHC ligands for use in the selective immunotherapy of autoimmune diseases associated with particular HLA alleles.Keywords
This publication has 40 references indexed in Scilit:
- Molecular Dynamics Simulation of MHC-Peptide Complexes as a Tool for Predicting Potential T Cell EpitopesBiochemistry, 1994
- Antigenic peptide binding by class I and class II histocompatibility proteinsStructure, 1994
- Tickling the TCR: selective T-cell functions stimulated by altered peptide ligandsImmunology Today, 1993
- Current perspectives in reactive arthritisImmunology Today, 1993
- Design, Activity, and 2.8 Å Crystal Structure of a C 2 Symmetric Inhibitor Complexed to HIV-1 ProteaseScience, 1990
- STRUCTURE, FUNCTION, AND DIVERSITY OF CLASS I MAJOR HISTOCOMPATIBILITY COMPLEX MOLECULESAnnual Review of Biochemistry, 1990
- Structural homologies between two HLA B27-restricted peptides suggest residues important for interaction with HLA B27International Immunology, 1990
- Guilt by association: HLA-B27 and ankylosing spondylitisImmunology Today, 1990
- Recognition of HLA-B27 and related antigen by a monoclonal antibodyHuman Immunology, 1982
- Partial purification and some properties of BB7.2 a cytotoxic monoclonal antibody with specificity for HLA-A2 and a variant of HLA-A28Human Immunology, 1981